Bukwang Pharm (003000) - Total Liabilities

Latest as of September 2025: ₩132.16 Billion KRW ≈ $89.56 Million USD

Based on the latest financial reports, Bukwang Pharm (003000) has total liabilities worth ₩132.16 Billion KRW (≈ $89.56 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Bukwang Pharm - Total Liabilities Trend (2007–2024)

This chart illustrates how Bukwang Pharm's total liabilities have evolved over time, based on quarterly financial data. See Bukwang Pharm short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Bukwang Pharm Competitors by Total Liabilities

The table below lists competitors of Bukwang Pharm ranked by their total liabilities.

Company	Country	Total Liabilities
Nanjing OLO Home Furnishing SHG:603326	China	CN¥744.69 Million
Drugs Made In America Acquisition Corp. Units NASDAQ:DMAAU	USA	$7.28 Million
Polaris Media OL:POL	Norway	Nkr1.93 Billion
Huizhong Instrumentation Co Ltd SHE:300371	China	CN¥107.14 Million
D. Boral Acquisition I Corp. Class A Ordinary Shares NASDAQ:DBCA	USA	$57.20K
Spirox Corp TW:3055	Taiwan	NT$307.69 Million
Fusion Micro Finance Limited NSE:FUSION	India	Rs58.39 Billion
Jiangsu Holly Corp SHG:600128	China	CN¥3.51 Billion

Liability Composition Analysis (2007–2024)

This chart breaks down Bukwang Pharm's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 003000 company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.60	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.39	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.28	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bukwang Pharm's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bukwang Pharm (2007–2024)

The table below shows the annual total liabilities of Bukwang Pharm from 2007 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩129.03 Billion ≈ $87.44 Million	-33.74%
2023-12-31	₩194.75 Billion ≈ $131.98 Million	+50.88%
2022-12-31	₩129.08 Billion ≈ $87.48 Million	+9.99%
2021-12-31	₩117.36 Billion ≈ $79.53 Million	-9.57%
2020-12-31	₩129.78 Billion ≈ $87.95 Million	+109.15%
2019-12-31	₩62.05 Billion ≈ $42.05 Million	-22.61%
2018-12-31	₩80.17 Billion ≈ $54.33 Million	+221.64%
2017-12-31	₩24.93 Billion ≈ $16.89 Million	+8.38%
2016-12-31	₩23.00 Billion ≈ $15.59 Million	-19.32%
2015-12-31	₩28.51 Billion ≈ $19.32 Million	+6.30%
2014-12-31	₩26.82 Billion ≈ $18.17 Million	-1.18%
2013-12-31	₩27.14 Billion ≈ $18.39 Million	-52.00%
2008-12-31	₩56.54 Billion ≈ $38.32 Million	+27.39%
2007-12-31	₩44.39 Billion ≈ $30.08 Million	--

About Bukwang Pharm

KO:003000 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$308.58 Million

₩455.34 Billion KRW

Market Cap Rank

#14772 Global

#496 in Korea

Share Price

₩4615.00

Change (1 day)

-3.35%

52-Week Range

₩3225.00 - ₩9600.00

All Time High

₩36947.85